We have a limited supply of COVID-19 vaccines and are offering them to eligible patients based on state and federal guidelines. Please do not call us for a vaccine appointment. We are notifying patients individually when they can schedule. so we can notify you. Learn more about the .
At NYU Langone’s Perlmutter Cancer Center, our High-Risk Cancer Genetics Program team works together to determine a person’s risk for developing cancer, help to facilitate genetic testing, and provide personalized management recommendations for cancer detection and care.
Ophira Ginsburg, MD | Director
Dr. Ginsburg is the director of the High-Risk Cancer Genetics Program. A medical oncologist with expertise in cancer genetics, prevention, and screening, she is an associate professor in the Departments of Medicine and Population Health at NYU Langone.
Dr. Ginsburg and her team of genetic counselors help families understand their risks for developing cancer and provide risk-reduction strategies. Her research focuses on identifying and reducing cancer health disparities in the United States and globally. Her research has been funded by the National Institutes of Health, Canadian Institutes for Health Research, and Grand Challenges Canada.
She has co-authored more than 100 publications, including peer-reviewed articles, commentaries, and book chapters about cancer genetics, cancer health disparities, and global women’s health.
Rachelle Chambers, MS, CGC | Manager, Genetic Counselor
Ms. Chambers is a board-certified genetic counselor and manager for the High-Risk Cancer Genetics Program. She leads a team of genetic counselors who provide hereditary cancer risk assessment at multiple clinical sites across Manhattan, Brooklyn, and Long Island. With more than 15 years of experience in clinical and cancer research genetics, Ms. Chambers holds a master’s degree in human genetics.
She is also the lead genetic counselor working on NYU Langone’s Cancer MoonshotSM study funded by the National Cancer Institute and in collaboration with the Huntsman Cancer Institute. Ms. Chambers has co-authored multiple papers on service delivery models in genetic counseling. Her professional and research interests include alternate service delivery models for genetic counseling services; expanding access to genetic counseling and testing services, universal tumor screening for Lynch syndrome; hereditary gastrointestinal cancer and related conditions; and psychosocial counseling for families who are at high risk for cancer.
Tamara Braid, MS, CGC
Ms. Braid is a board-certified genetic counselor with a master’s degree in human genetics. As part of the team of genetic counselors, Ms. Braid has worked to implement a telehealth genetic counseling service for men who have received a diagnosis for prostate cancer. Her research interests focus on expanding models of genetic counseling and using technology to assess the genetic counseling needs of men who have prostate cancer.
Anna Cantor, MA, MS, CGC
Ms. Cantor is a board-certified genetic counselor with master’s degrees in human genetics and in behavioral neuroscience, who specializes in adult and pediatric cancer genetics. She is co-lead clinical supervisor for genetic counseling students from Sarah Lawrence College. Her clinical interests include increasing knowledge about cancer genetics among healthcare providers, and promoting awareness about BRCA genetic mutations in the Ashkenazi Jewish community.
Jessica Everett, MS, CGC
Ms. Everett is a clinical assistant professor of internal medicine and a board-certified genetic counselor at Perlmutter Cancer Center’s Pancreatic Cancer Center at NYU Langone. She has more than 20 years of clinical and research experience in cancer genetics. Her professional and research interests include genetics and pancreatic cancer, and improvement of access and service delivery to meet the growing clinical need for genetics expertise.
Sarah Gerrard, MS, CGC
Ms. Gerrard is a board-certified cancer genetic counselor with a master’s degree in human genetics. She was instrumental in launching the program’s online group webinar and genetic testing for hereditary cancer syndromes. Her research interests include alternative service delivery models for genetic counseling and the evolving field of testing for hereditary cancer risk.
Elizabeth Manderski, MS, CGC
Ms. Manderski is a board-certified cancer genetic counselor with a master’s degree in human genetics. Her clinical interests include providing care for families with all types of hereditary cancer predisposition syndromes. She is committed to improving the patient experience at NYU Langone and is an active participant in various community outreach projects. She also serves as a genetics educator both within NYU and in the greater New York City area.
Jessica Martineau, MS, CGC, Genetic Counselor
Ms. Martineau is a board-certified genetic counselor who specializes in cancer genetics. She holds a master’s degree in human genetics. She is co-lead clinical supervisor for genetic counseling students at Sarah Lawrence College. Her professional and research interests include hereditary gynecologic cancers, cancer susceptibility in rare genetic syndromes, and psychosocial counseling for those who have family history of cancer.
LeeAnn McCoy, MS, CGC
Ms. McCoy is a board-certified genetic counselor who specializes in cancer genetics. With a master of science degree in genetic counseling, Ms. McCoy’s professional and research interests include hereditary breast cancer, colorectal cancer syndromes, and cancer susceptibility in rare genetic syndromes. She is also involved in promoting awareness of hereditary cancer indications to healthcare providers and psychosocial counseling for families at high risk of cancer
Melanie McDermet, MS, CGC
Melanie McDermet, MS, is a genetic counselor at Perlmutter Cancer Center at NYU Langone Hospital—Long Island, specializing in cancer genetics. She has lectured on cancer and genetics to diverse audiences, including obstetrics and pediatric physicians; prenatal and pediatric patients; other genetic counselors; and high school, college, nursing, and physician groups. Ms. McDermet holds a master’s degree in human genetics from the University of Michigan and is certified by the American Board of Genetic Counseling.
Melanie Roberts, MS, CGC
Ms. Roberts is a board-certified cancer genetic counselor with a master’s degree in genetic counseling. Before joining NYU Langone, Ms. Roberts established cancer genetic counseling programs at other medical centers. She has a clinical interest in gastrointestinal cancer genetic syndromes, helping to identify patients at risk. Additionally, she has interests in the psychosocial impact of genetic information on individuals and families.
Forum Shah, MS, CGC
Ms. Shah is a board-certified genetic counselor who established the high-risk cancer genetics program at NYC Health + Hospitals/Bellevue. She holds a master’s degree in genetic counseling. She is working to extend the program to provide cancer genetic counseling services at other NYC Health + Hospitals where those services are not available. She also co-hosts support group meetings for men and women with inherited cancer syndromes. Her research interests center on racial disparities in genetic counseling services and cancer genetic testing.
Shalena Alleyne, Medical Secretary
Ms. Alleyne is the medical secretary for the High-Risk Cancer Genetics Program. She builds partnerships with the program’s referring physicians and advocates for patients.
John Pappas, MD
Dr. Pappas is a clinical geneticist and associate professor of pediatrics at NYU Langone. He directs clinical genetics services for NYU Langone’s Department of Pediatrics. He studies the characteristics and genetics of hereditary syndromes and provides evaluations for genetic diagnosis and treatments for children and adults, believing that detailed phenotyping and genotyping can improve our understanding of genetic factors in disease and lead to the development of new treatments.
Diane M. Simeone, MD
Dr. Simeone is an internationally recognized expert in pancreatic cancer. She is the director of the Pancreatic Cancer Center and focuses on the early detection and treatment of pancreatic cancer to improve survival rates. She studies the molecular events that lead to pancreatic cancer and works to translate laboratory research into clinical practice.
Kathie-Ann Joseph, MD, MPH
Dr. Joseph is a surgical oncologist at NYU Langone’s Perlmutter Cancer Center and co-director of the Beatrice W. Welters Breast Health Outreach and Navigation Program, where she works to identify and educate women who could benefit from breast cancer screening through outreach in their community.
Julia A. Smith, MD
Dr. Smith is a medical oncologist at Perlmutter Cancer Center and clinical assistant professor of medicine at NYU Grossman School of Medicine. She sees people who are at high risk for developing cancer.